Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 12/20 | 0.46 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.46 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.46 |
| ▸ | GGH | Q92820 | 1/20 | 0.40 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.38 |
| ▸ | KDM4A | O75164 | 2/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.38 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.38 |
| ▸ | TET3 | O43151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6009547 | 0.98 | FOLH1 (0.44) | FOLH1NAALAD2RIMKLAGGHTET2 | |
| SCHEMBL28491840 | 0.87 | KMT2A (0.38) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL6009834 | 0.84 | TGFBR1 (0.40) | — | |
| SCHEMBL6010380 | 0.81 | FOLH1 (0.39) | FOLH1 | |
| SCHEMBL28008104 | 0.80 | FOLH1 (0.53) | FOLH1NAALAD2RIMKLAGGHTET2 | |
| SCHEMBL28008105 | 0.80 | FOLH1 (0.53) | FOLH1NAALAD2RIMKLAGGHTET2 | |
| SCHEMBL6009533 | 0.80 | FOLH1 (0.44) | FOLH1 | |
| SCHEMBL6010244 | 0.80 | MAPK1 (0.41) | — | |
| SCHEMBL6009842 | 0.79 | KDM4E (0.40) | FOLH1 | |
| Hydrochloric Acid SCHEMBL6010128 | 0.78 | FOLH1 (0.43) | FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | SEIWA KASEI COMPANY, LIMITED (JP) | 2006-01-26 | — | — | US | disclosed |
| EP-1584320-A1 | COSMETIC PREPARATION CONTAINING GLYCERYLAMINO ACID DERIVATIVE | Seiwa Kasei Company, Limited (JP) | 2005-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | GLA, GPKOW, CUTA | FOLH1 1267/4885NAALAD2 114/4885RIMKLA 1373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.